Lv1
18 积分 2025-06-04 加入
Development of Highly Optimized Antibody–Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia
1个月前
已完结
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
3个月前
已完结
Molecular Design and Preclinical Evaluation of GenSci143, a Novel B7-H3- and PSMA-Directed Bispecific Antibody-Drug Conjugate, for the Treatment of Prostate Cancer
3个月前
已完结
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
4个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
5个月前
已完结
The therapeutic window of antibody drug conjugates: A dogma in need of revision
9个月前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
9个月前
已完结
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment
9个月前
已完结
Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody
10个月前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
11个月前
已完结
皖公网安备34019202002308
